Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves IND application for clinical study of RK-01

June 11, 2018

Updated interim data from phase I/II study of lumasiran for primary hyperoxaluria type 1

June 8, 2018

Minesapride shows clinical efficacy in irritable bowel syndrome with constipation

June 8, 2018

Luye Pharma and Elpis expand collaboration in immuno-oncology

June 8, 2018

First celiac disease model with a humanized immune system reported

June 8, 2018

MyoKardia opens phase III study of mavacamten in symptomatic obstructive hypertrophic cardiomyopathy

June 8, 2018

TET2 disruption improves antitumor activity of CAR T-cell therapy in a CLL patient

June 8, 2018

Roche patents anti-pY796-DDR1 antibodies

June 8, 2018

Mitochondrial aging in directly induced neurons may help understand neurodegenerative diseases

June 8, 2018

Seoul National University creates adenoviral vector encoding CRY1

June 8, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.